IXIFI

Indicated For

Crohn's disease, Ulcerative colitis

About This Medication

# PfizerFlex Patient Support Program Patient Guide: How to Get IXIFI (infliximab-qbtx) at Low or No Cost IXIFI (infliximab-qbtx) is a biosimilar medication used to treat conditions like rheumatoid arthritis, Crohn's disease, and psoriasis by reducing inflammation through targeting tumor necrosis factor (TNF). The **PfizerFlex Patient Support Program** helps eligible patients access IXIFI at low or no cost via copay assistance or free medication for uninsured or underinsured individuals[1][3][6]. ## Who Qualifies for the Program? The PfizerFlex program supports patients with commercial insurance through copay help and offers free medication to those without coverage who meet financial criteria. Key eligibility includes: - A valid prescription for **IXIFI** from a healthcare provider. - **Commercial insurance** for copay assistance; Medicare or federal insurance often ineligible for free drug programs[4][8]. - Household income typically at or below **300% of the Federal Poverty Level (FPL)** for free medication, though exact thresholds for IXIFI are not specified in sources—check www.PfizerRxPathways.com for updates[8][9]. Patients with an FDA-approved diagnosis and inability to afford treatment are prioritized. Caregivers or providers can assist with enrollment[1][5]. ## About IXIFI (infliximab-qbtx) **IXIFI** is an intravenous (IV) biosimilar to Remicade, administered by infusion at a clinic or hospital every 4-8 weeks after initial doses. It blocks TNF-alpha, a protein causing inflammation in autoimmune diseases. Common uses: - Moderate to severe rheumatoid arthritis (with methotrexate). - Crohn's disease or ulcerative colitis. - Plaque psoriasis, ankylosing spondylitis, psoriatic arthritis. Infusions last 2 hours; monitor for side effects like infections or infusion reactions. Always follow your doctor's guidance[7]. ## Income Eligibility Breakdown Income limits are not explicitly listed for IXIFI, but Pfizer programs generally cap at **300% FPL** for free meds. Use the table below for 2026 FPL estimates (actuals vary; verify via program site). No thresholds mean case-by-case review. | Household Size | 100% FPL | 300% FPL (Estimated Max) | |---------------|----------|--------------------------| | 1 | $15,060 | $45,180 | | 2 | $20,440 | $61,320 | | 3 | $25,820 | $77,460 | | 4 | $31,200 | $93,600 | *Notes: Pre-tax household income. Provide tax returns, W-2s, or paystubs. Electronic verification available[4][5][8][9].* ## Insurance Requirements - **Commercial insurance eligible**: Copay cards reduce out-of-pocket to $0-$5 per infusion[7]. - **Uninsured/underinsured**: Qualify for free IXIFI if income-eligible. - **Medicare/Medicaid**: Often ineligible for free program; explore other aid[4][8]. - Provider/pharmacy confirms costs; certify unaffordability[1][8]. ## Step-by-Step Application Process 1. **Visit PfizerRxPathways.com**: Use Program Finder, enter **IXIFI**[1]. 2. **Complete Enrollment**: Online via Pfizer PAP Connect (patient + prescriber register), download form, or call 1-855-935-FLEX (3539)[1][6][10]. 3. **Gather Documents**: Proof of income (1040, W-2, paystubs, SSA-1099), insurance info, prescription[4][5]. 4. **Prescriber Signs**: They complete clinical sections[5]. 5. **Submit**: Mail to P.O. Box 66585, St. Louis, MO 63166-6585; fax 866-470-1748; or online[5]. 6. **Care Coach Contact**: Enroll for nurse support within 1 business day[2][6]. For copay: HCP enrolls via Pfizer enCompass; get card instantly if approved[7]. ## Timeline and Delivery - **Review**: 2-3 weeks for PAP; 3 business days online[1][10]. - **Notification**: Letter with status, enrollment term (often 1 year), next steps[5]. - **Delivery**: **IV infusion** at clinic/specialty pharmacy; program ships to site[7]. - Copay approval: Immediate card[7]. ## Alternatives if Denied - **Biosimilars**: Remicade, Inflectra, Avsola, Renflexis—similar efficacy, potentially lower cost[provided]. - Other Pfizer programs (Oncology Together, RxPathways)[3][9]. - NeedyMeds, PAN Foundation, or state aid. - Appeal denial or reapply with updated docs[1]. ## Disclaimer This guide is for informational purposes; eligibility varies. Contact PfizerFlex at 1-855-935-FLEX (3539) or PfizerRxPathways.com for latest details. Not medical advice—consult your doctor. Program terms subject to change[1][6].

Program information last verified: March 30, 2026